相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stimulation of exosome biogenesis by adiponectin, a circulating factor secreted from adipocytes
Shunbun Kita et al.
JOURNAL OF BIOCHEMISTRY (2021)
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Sebastiano Buti et al.
EUROPEAN JOURNAL OF CANCER (2021)
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer
Paola Marie Marcovecchio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Abdelkrim Hmadcha et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice
Yuto Nakamura et al.
MOLECULAR THERAPY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice
Hao Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome
Ana Luisa Perdigoto et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors
Sho Yoneda et al.
DIABETES CARE (2019)
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes
Venessa H. M. Tsang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Andreas Robert Rudolf Weiss et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes
Anupam Kotwal et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy
Megu Yamaguchi Baden et al.
DIABETOLOGY INTERNATIONAL (2019)
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
Angeliki Stamatouli et al.
DIABETES (2018)
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Yufang Shi et al.
NATURE REVIEWS NEPHROLOGY (2018)
Role of PD-1 during effector CD8 T cell differentiation
Eunseon Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
Kevin C. Osum et al.
SCIENTIFIC REPORTS (2018)
The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment
Danielle G. Leuning et al.
SCIENTIFIC REPORTS (2018)
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens A Systematic Review and Meta-analysis
Romualdo Barroso-Sousa et al.
JAMA ONCOLOGY (2018)
Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
Jun Liang et al.
STEM CELL RESEARCH & THERAPY (2018)
Endocrine side effects of cancer immunotherapy
Priscilla Cukier et al.
ENDOCRINE-RELATED CANCER (2017)
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
Jeroen de Filette et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Per-Ola Carlsson et al.
DIABETES (2015)
Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice
Takafumi Imai et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study
Anil Bhansali et al.
CELL TRANSPLANTATION (2014)
Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice
Isotta Chimenti et al.
CIRCULATION RESEARCH (2010)
Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells
A. M. Madec et al.
DIABETOLOGIA (2009)
NFATc1 regulates PD-1 expression upon T cell activation
Kenneth J. Oestreich et al.
JOURNAL OF IMMUNOLOGY (2008)
Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners
Toshiaki Hanafusa et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes
J Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses
F Tsushima et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
分享论文
